Episode 151: PREMIUM Aiming high and long with two studies that should impact practice
In episode 151, James and Mike start of the new year with premium information so, by law we had to put it in a PREMIUM podcast. The first study we looked at was AIM-HIGH which showed us that we might need to re-assess how we use niacin and we finally have some reasonable data that helps us figure out how long to stay on a bisphosphonate.
Show notes
1) AIM-HIGH – Niacin added to statins in patients with cardiovascular disease
N Engl J Med 2011; 365:2255-67
2) The idolatry of the surrogate
3) HORIZON-Pivotal Fracture Trial – using zoledronic acid for 3 years or 6 years
J Bone Min Res 2011 DOI:10.1002/jbmr.1494
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
